Prostate cancers that are missed on multiparametric (mp)MRI are small and “not life-threatening,” according to an analysis of data from the Prostate MR Imaging Study (PROMIS). “Our work suggests that MRI scans of the prostate appear to deliver crucial information about a man’s risk of dying from prostate cancer, even before he has a biopsy,”
0 Comments
A talk by Charles A. Czeisler, MD, PhD, FRCP, Baldino Professor of Sleep Medicine and director, Division of Sleep Medicine, Harvard Medical School; chief, Division of Sleep Medicine, Brigham and Women’s Hospital. Moderated by Freda C. Lewis-Hall, MD, DFAPA, executive vice president and chief medical officer, Pfizer, and member of the HMS Board of Fellows.
0 Comments
This is a pre-surgical video which describes rotationplasty, who the procedure is appropriate for and possible complications. This video depicts the process of being fitted for a prosthesis and learning to use it. The patient describes her active and satisfying life after rotationplasty, her emotions and the process of adjusting to living with a prosthesis.
0 Comments
Print this page CAMBRIDGE, Mass.–(BUSINESS WIRE)–Jul. 14, 2020– Moderna, Inc., (Nasdaq:MRNA) a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, today announced the publication of an interim analysis of the open-label Phase 1 study of mRNA-1273, its vaccine candidate against COVID-19, in The New
0 Comments
Treatment for Molluscum Contagiosum Verrica Pharmaceuticals Receives Complete Response Letter from the FDA for its New Drug Application for VP-102 for the Treatment of Molluscum Contagiosum Print this page WEST CHESTER, Pa., July 14, 2020 (GLOBE NEWSWIRE) – Verrica Pharmaceuticals Inc. (“Verrica”) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for viral skin diseases requiring medical interventions, today announced
0 Comments
Print this page HORSHAM, PA, July 14, 2020 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the U.S. Food and Drug Administration (FDA) has approved Tremfya (guselkumab) for adult patients with active psoriatic arthritis (PsA), a chronic progressive disease characterized by painful joints and skin inflammation.[1],[2] Tremfya is the first treatment
0 Comments
Reviewed by Emily Henderson, B.Sc.Jul 14 2020 For the first time in the world, an international study team with substantial participation from researchers from the Comprehensive Cancer Center (CCC) of MedUni Vienna and Vienna University Hospital identifies the molecular differences between individual tumor cells in ependymomas, which are an aggressive type of brain tumor. The
0 Comments
We know that it has been harder for people to stay active over these last several weeks. Christina Lombardi, DPT PT has put together easy stretches to get you moving at home! Each Wednesday for the next several weeks we will share these stretches with you. Each stretch includes descriptive information and a video to
0 Comments
Whether we’re struggling with FOMO, or constantly falling into comparison traps, comparing ourselves to others is making us miserable. But it doesn’t have to be this way When was the last time you felt the prickly sting of comparison? You know the feeling: the hot frustration that starts in your belly, and rises to your
0 Comments
Quarantining at home for the past few months considerably reduced professional and socializing activities. Added to the sense of isolation from stay-at-home orders, other factors including unemployment, financial troubles, and the threat of COVID-19 infection and death has significantly increased stress levels for many people. One researcher from the United States recently published a piece suggesting that psychosocial
0 Comments
Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Here are the coronavirus stories Medscape’s editors around the globe think you need to know about today: Blood Test Signals Risk? A low lymphocyte count in people presenting to the hospital with COVID-19 could help physicians identify those at higher risk
0 Comments
Two experts in geriatric diabetes are offering some contemporary practical recommendations for diabetes management in older adults during the COVID-19 pandemic.   The viewpoint, entitled, ”Caring for Older Adults With Diabetes During the COVID-19 Pandemic,” was published online in JAMA Internal Medicine by Medha N. Munshi, MD, director of the geriatrics program at the Joslin Diabetes Center,
0 Comments
avacopan Treatment for ANCA-Associated Vasculitis ChemoCentryx Submits New Drug Application to the U.S. FDA for Avacopan in ANCA-Associated Vasculitis Print this page MOUNTAIN VIEW, Calif., July 09, 2020 (GLOBE NEWSWIRE) – ChemoCentryx, Inc., (NASDAQ: CCXI) today confirmed that the Company has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for avacopan for the treatment
0 Comments
Print this page CAMBRIDGE, Mass.–(BUSINESS WIRE) July 09, 2020 –Ipsen Biopharmaceuticals, an affiliate of Ipsen (Euronext: IPN; ADR: IPSEY), announced today that the United States Food and Drug Administration (FDA) has approved the expanded use of Dysport (abobotulinumtoxinA) in pediatric patients. When Dysport was first FDA-approved in 2016 for pediatric lower limb spasticity, Ipsen was
0 Comments
Beads hang from tree limbs on the campus of Tulane University, New Orleans, Louisiana. Education Images | Getty Images Tulane University, which has long been ranked as one of the best party schools in the nation, is threatening expulsion for students attending big bashes after “truly shameful” partying drew negative attention to the New Orleans
0 Comments
Extremely preterm children have very low birth weights, underdeveloped organs, and risks of long-term problems or disabilities. Antenatal treatment — therapy given before birth — can improve outcomes in preterm children. Statistical analysis of medical records can tell clinicians which antenatal treatments can best protect against severe neurodevelopmental impairment or death. The UAB News Studio
0 Comments
Hydroxychloroquine (HCQ) helped reduce recurrent maternal autoantibody-mediated congenital heart block (CHB) in fetuses, an open-label study suggested. Anti-SSA/Ro-positive mothers who had had a previous pregnancy complicated by CHB who took HCQ 400 mg daily, starting before completion of gestational week 10, had a 7.4% rate of clinically-relevant fetal CHB (second- or third-degree) at any time
0 Comments